• Our Solution
    • Physicians
    • Patients
  • About Artrya
    • Who we are
    • Board of Directors
    • Careers
  • Investor Relations
    • Overview
    • ASX Announcements
    • Corporate Governance
    • Company Research
  • Contact Us
Request a demonstration

Change of Director’s Interest Notice – J Barrington

Change in Substantial Holding – Artrya

Notification regarding unquoted securities – AYA

Change in Director’s Interest Notice – J Barrington

Release of shares from voluntary escrow

Chairman and Managing Director Addresses to AGM

Notification of cessation of securities – AYA

Initial Director’s Interest Notice

Notification regarding unquoted securities – AYA

Artrya – Bell Potter Health Care Conference 2022

1 2 3 4 … 6 Next

Precise diagnosis. Personalized treatment.
Preventative care.

Choose Artrya as your trusted clinical partner.

Contact us today
Coronary artery disease.
We see you.

Sign up to our newsletter

Request a Demo
Contact Us

About Artrya
Investor Relations

Location
1257 Hay Street, West Perth, 6005
Follow us
X
LinkedIn

Salix Coronary Anatomy is listed on the Australian Register of Therapeutic Goods, ID 347719. Salix Central USA product (K243038) is cleared in the USA. For the availability of Salix in The EU, UK, or other jurisdictions, please contact us.

© 2025, Artrya. All rights reserved. Privacy Policy Terms and Conditions Indications for Use